Results 81 to 90 of about 8,933 (160)

PERANAN IDARUCIZUMAB UNTUK MENETRALISIR EFEK ANTIKOAGULAN DABIGATRAN [PDF]

, 2019
Latar Belakang: Dabigatran etexilate (Pradaxa) telah disetujui oleh FDA dan Uni Eropa sebagai antikoagulan untuk mencegah stroke dan emboli sistemik pada pasien dengan atrial fibrilasi non-valvular dan satu atau lebih faktor risiko lain.
Soejitno, Andreas, Putra, Ida Bagus Kusuma   +1 more
core   +1 more source

Economic evaluation of dabigatran etexilate for the primary prevention of venous tromboembolic events following major orthopedic surgery in the netherlands [PDF]

, 2012
OBJECTIVES: Dabigatran etexilate is a new oral direct thrombin inhibitor for prophylaxis of venous thromboembolism (VTE) in patients who have elective surgery for total hip replacement (THR) or total knee replacement (TKR).
Kappelhoff, B.S., Brouwers, J.R., Postma, M.J.; id_orcid, van Hulst, M.; id_orcid   +3 more
core   +4 more sources

Dabigatran etexilate: a direct thrombin inhibitor

Italian Journal of Medicine, 2013
BACKGROUND Direct Thrombin Inhibitors (DTIs) represent a new and promising class of anticoagulants. Unlike heparin, they directly interact with thrombin and block fibrinogen binding.
M. Dugnani
doaj   +1 more source

The Complementary Effects of Dabigatran Etexilate and Exercise Training on the Development and Stability of the Atherosclerotic Lesions in Diabetic ApoE Knockout Mice. [PDF]

Pharmaceuticals (Basel), 2023
Kadoglou NP, Stasinopoulou M, Gkougkoudi E, Christodoulou E, Kostomitsopoulos N, Valsami G.   +5 more
europepmc   +1 more source

DABIGATRAN ETEXILATE IN ELDERL Y PATIENTS WITH ATRIAL FIBRILLATION: WHATS NEW?

Евразийский Кардиологический Журнал, 2017
The article discusses stroke prevention in elderly patients with atrial fibrillation. The principles of choosing anticoagulant therapy in this group of patients are discussed.
O. N. Tkacheva, N. M. Vorobyeva
doaj   +1 more source

Population pharmacokinetic analysis for dabigatran etexilate in Chinese patients with non-valvular atrial fibrillation. [PDF]

Front Cardiovasc Med, 2022
Liu YO, Xie QF, Liu ZY, Wang Z, Mu GY, Zhang YT, Zhao ZN, Yuan DD, Guo LP, Wang N, Xiang J, Song HT, Jiang J, Xiang Q, Cui YM.   +14 more
europepmc   +1 more source

Dabigatran etexilate for the treatment of acute venous thromboembolism in children (DIVERSITY): a randomised, controlled, open-label, phase 2b/3, non-inferiority trial

, 2020
Dabigatran etexilate is a direct oral anticoagulant with potential to overcome the limitations of standard of care in children with venous thromboembolism.
Reschke, Madlen, Simetzberger, Monika, Mondelaers, Veerle, Groll, Andreas, Aytac, Selin, Trunina, Inna, van Geet, Christel, Halton, Jacqueline, Lvova, Olga, Huang, Fenglei, Lin, Ming-Chih, Revel-Vilk, Shoshana, Kiss, Csongor, Galustyan, Anna, Mitchell, Lesley G, Van Damme, An, Gorbatikov, Kirill, Tartakovsky, Igor, Annichino Bizzacchi, Joyce Maria, Zilinskaite, Virginija, Onelda Elena, Graciela, Chalmers, Elizabeth, Mazzucconi, Maria Gabriela, Croteau, Stacey E, Albisetti, Manuela, Glosli, Heidi, Hadacova, Ivana, Fuzzato Silva, Luciano, Corrales-Medina, Fernando, Paredes Aguilera, Rogelio Alejandro, Novak, Zbynek, Reilly, Paul, Zvereva, Tatiana, Svirin, Pavel, Montes Tapia, Fernando Felix, Felgenhauer, Judy, Caliskan, Umran, Hoffmann, Marianne, Brandão, Leonardo R, Safina, Asiya, Cockrell, Erin, Kuhn, Tomas, Dmytriiev, Dmytro, Luciani, Matteo, Votava, Tomas, Loggetto, Sandra, Kreuzer, Jörg, Digtyar, Valeriy, Halimeh, Susan, Amid, Ali, Brueckmann, Martina, Bomgaars, Lisa, Carneiro, Jorge, Fu, Yun-Ching, Nurmeev, Ildar, Sevilla, Julian, Odri-Komazec, Irena, Kavakli, Ramazan Kaan, Labarque, Veerle, Woods-Swafford, Wendy, Ozdemir, Nihal, Frisk, Tony, Sosothikul, Darintr, Chistolini, Antonio, Kattamis, Antonis, Kerr Saraiva, José, Zapletal, Ondrej, Damgaard, Michael, Male, Christoph, Palmu, Sauli, Pawar, Anjali, Couturaud, Francis, Celkan, Tiraje, Druzgal, Colleen Harkins, Sharathkumar, Anjali, Aarli, Aanen, Dixon, Natalia, Gropper, Savion, Wulff, Beate, Sasmaz, Ilgen, Sun, Zhichao, Kupesiz, Alphan, Hak, Jiri, Trenor III, Cameron, David, Michele, Saracco, Paola   +85 more
core   +1 more source

DABIGATRAN ETEXILATE FOR THE TREATMENT OF VENOUS THROMBOEMBOLIC COMPLICATIONS

Атеротромбоз, 2015
This article discusses the significant features and use of new oral anticoagulant dabigatran etexilate for the treatment of venous thromboembolic complications (VTC).
N. M. Vorobieva, E. P. Panchenko
doaj   +1 more source

Possible Interaction between Dabigatran and Ranolazine in Patients with Renal Failure

Medicina, 2019
Dabigatran etexilate is a direct oral anticoagulant (thrombin inhibitor) used for the prevention of stroke and systemic thromboembolic events in patients with permanent atrial fibrillation; prevention of venous thromboembolic events and deep veins ...
Gintautas Gumbrevičius, Gytė Damulevičienė, Vaidotas Galaunė, Milda Gumbrevičiūtė   +3 more
doaj   +1 more source

Physiologically-based pharmacokinetic modeling to predict drug-drug interactions of dabigatran etexilate and rivaroxaban in the Chinese older adults. [PDF]

Eur J Pharm Sci, 2023
Sia JEV, Lai X, Wu X, Zhang F, Li H, Cui C, Liu D.   +6 more
europepmc   +1 more source